YSIOS | Archive
Ysios Capital Partners and “la Caixa” lead MedLumics 3.5 Million Euro/4.7 Million USD Series A Financing. 01.12.11
 
Ysios Capital Partners leads €29.2 Million Series D Financing of AM-Pharma. 13.09.11
 
Ysios leads €2M series A financing of STAT Diagnostica. 15.06.11
 
AMGEN to acquire BIOVEX, a privately held biotechnology company headquartered in Woburn, Mass. 25.01.11
Ysios Capital Partners leads €5 Million Series A Financing of Sabirmedical. 15.09.10
Ysios participates in Cardoz' €10 million Series A financing round. 10.05.10
 
 PORTFOLIO | Archive
TiGenix rheumatoid arthritis Phase IIa study opens third and last cohort. 01.02.12
 
Endosense launches TactiCath 75 force-sensing catheter, announces new results of EFFICAS clinical study. 12.01.12
 
AM-Pharma Announces Appointment of Russell Greig as Chairman. 12.01.12
 
TiGenix Reports Positive Results of ChondroCelect. Compassionate Use Program. 09.01.12
 
TiGenix obtains € 2.9 Million FP7 grant to fund development of Cx611 in rheumatoid arthritis. 23.12.11
 
TiGenix receives green light to start Phase I with Cx621. 20.12.11
 
 
 Ysios Capital Partners | Contact | Español | Design by amc | Ysios © 2010